Preclinical Evaluation of Cudetaxestat for Potential Drug-Drug Interactions

被引:0
|
作者
Yu, W. [1 ]
Rajagopalan, R. [1 ]
Lin, J. [1 ]
Ibrahim, P. [1 ]
机构
[1] Blade Therapeut Inc, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2719
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Clinical Evaluation of Cudetaxestat for Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Potential Drug-Drug
    Mody, D.
    Yu, W.
    Lin, J.
    Ibrahim, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [2] EVALUATION OF POTENTIAL DRUG-DRUG INTERACTIONS WITH BARICITINIB
    Payne, C.
    Zhang, X.
    Shahri, N.
    Williams, W.
    Cannady, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1063 - 1063
  • [3] The scientific basis of drug-drug interactions: Mechanism and preclinical evaluation
    Li, AP
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (03): : 657 - 664
  • [4] The Scientific Basis of Drug-Drug Interactions: Mechanism and Preclinical Evaluation
    Albert P. Li
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 : 657 - 664
  • [5] Evaluation of potential drug-drug interactions in a pediatric population
    Bebitoglu, Berna Terzioglu
    Oguz, Elif
    Nuhoglu, Cagatay
    Dalkilic, Ayse Ela Kurtdan
    Cirtlik, Pelin
    Temel, Fatime
    Hodzic, Ajla
    [J]. TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2020, 55 (01): : 30 - 38
  • [6] Evaluation of potential drug-drug interactions with medical cannabis
    Ho, Jessie Jia Yi
    Goh, Chenyi
    Leong, Caitlin Shen Ai
    Ng, Khuen Yen
    Bakhtiar, Athirah
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [7] Evaluation of potential drug-drug interactions in psychiatric patients
    Todorova-Nenova, K.
    Zhelyazkova-Savova, M.
    Gancheva, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S258 - S259
  • [8] Evaluation of potential drug-drug interactions in intensive care unit
    Dagdelen, M. S.
    Gulen, D.
    Ceylan, I
    Girgin, N. K.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5801 - 5806
  • [9] Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions
    Snyder, Ben D.
    Rowland, Andrew
    Polasek, Thomas M.
    Miners, John O.
    Doogue, Matthew P.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (09) : 1115 - 1122
  • [10] Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions
    Ben D. Snyder
    Andrew Rowland
    Thomas M. Polasek
    John O. Miners
    Matthew P. Doogue
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 1115 - 1122